Who is the founder of the company? Yves Levy. He is also the director called Vaccine Research Institute. The current company is a spin-off of VRI which happened in August 2020.
Yves Lévy wrote a bunch of papers on trials using CYT107 solely owned by RevImmune. The company is also the partner of Oncovir. The HIV vaccine the company did the trial does include poly-iclc as adjuvant. No obvious and direct connection which would trigger SEC filing from NWBO. But indirect connection does exist.
Market Data 
Markets 
AI
